Over-the-counter medication · Nasal Corticosteroid
budesonide nasal
Also sold as Rhinocort. Rhinocort temporarily relieves allergy symptoms.
Data updated 2026-05-15
- OTC
- Availability
budesonide nasal (Rhinocort) is an over-the-counter Nasal Corticosteroid. Rhinocort temporarily relieves allergy symptoms.
Rhinocort is a nasal spray that helps relieve allergy symptoms. It contains budesonide, a type of steroid that reduces inflammation in your nose.
Verify with FDA → · CMS NADAC pricing →
What it does
Rhinocort temporarily relieves allergy symptoms.
Common side effects
No common side effects listed.
Key warnings
The growth rate of some children may be slower while using this product.
The sections below are summarized in plain English from budesonide nasal's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Budesonide is a steroid that reduces inflammation. When sprayed into your nose, it reduces swelling and irritation. This helps to relieve your allergy symptoms.
Serious Warnings
The growth rate of some children may be slower while using this product. If a child 6 to under 12 years of age needs to use the spray for longer than two months a year, talk to their doctor.
Common Questions
How do I prime the bottle?
How often should I use the spray?
What if my symptoms don't improve?
Can children under 6 use this?
What if I spray it in my eyes?
Can I use this for a cold?
Do I need to shake the bottle?
What if I miss a dose?
How should children 6 to under 12 years of age use this spray?
What should I do if my child needs to use the spray for longer than two months a year?
What drug class is budesonide nasal?
Related Medications in Nasal Corticosteroid
Other drugs grouped near budesonide nasal - same-class peers and common alternatives.
azelastine
Astelin, Astepro
Azelastine nasal spray is an antihistamine medicine.
Compare with budesonide nasal →
cetirizine
Zyrtec
Cetirizine (Zyrtec) is an antihistamine medicine.
Compare with budesonide nasal →
chlorpheniramine
Chlor-Trimeton
Chlorpheniramine is an antihistamine medicine.
Compare with budesonide nasal →
ciclesonide nasal
Omnaris, Zetonna
Omnaris Nasal Spray is a medicine that helps treat allergy symptoms in your nose.
Compare with budesonide nasal →
desloratadine
Clarinex
Desloratadine is an antihistamine medicine.
Compare with budesonide nasal →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Pain Relievers Compared
NSAIDs vs acetaminophen, which OTC pain reliever to use
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
What the FDA Data Shows for budesonide nasal
The FDA label for budesonide nasal (sold under brand names such as Rhinocort) classifies it as an over-the-counter product in the Nasal Corticosteroid class. Rhinocort temporarily relieves allergy symptoms. Labeling covers dosing, contraindications, and monitoring requirements derived from clinical trials.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. Interaction data is drawn directly from FDA-approved prescribing information. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: August 5, 2025
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages